Watch STOK. Know when insiders buy.
One email the day a filing lands. Free.
STOK
Stoke Therapeutics, Inc.
25.70
+0.02 +0.08%
USD · close Oct 22
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
66
PASS · insiders 41, shorts 90
Insiders, 90 days
−$187K
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.7BP/E —DIV YIELD —FCF YIELD -10.90%REV TTM $27.6M −86.2%NET INCOME −$207.9M −496.1%NET CASH —52W 22.37 – 38.35NEXT EARNINGS Nov 3 EST.SEC XBRL · TTM TO Invalid Date
How STOK rewrote its risk factors
We haven’t read STOK’s 10-K risk factors yet. The sweep covers about 40 companies a day across the fundamentals universe.